In a final push before the closing of the year, the FDA deemed it fit to clear even long pending ones, including Flexion Therapeutics Inc’s (NASDAQ: FLXN ) sNDA for the updation of the label for its osteoarthritis … …read more
Source:: Yahoo Finance